Comparison of commercial dosimetric software platforms in patients treated with (177)Lu‐DOTATATE for peptide receptor radionuclide therapy

PURPOSE: The aim of this study was to quantitatively compare five commercial dosimetric software platforms based on the analysis of clinical datasets of patients who benefited from peptide receptor radionuclide therapy (PRRT) with (177)Lu‐DOTATATE (LUTATHERA(®)). METHODS: The dosimetric analysis was...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Med Phys
Autors principals: Mora‐Ramirez, Erick, Santoro, Lore, Cassol, Emmanuelle, Ocampo‐Ramos, Juan C., Clayton, Naomi, Kayal, Gunjan, Chouaf, Soufiane, Trauchessec, Dorian, Pouget, Jean‐Pierre, Kotzki, Pierre‐Olivier, Deshayes, Emmanuel, Bardiès, Manuel
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
COMPUTATIONAL AND EXPERIMENTAL DOSIMETRY
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7589428/
https://ncbi.nlm.nih.gov/pubmed/32632928
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mp.14375
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars